Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China · Delayed Price · Currency is CNY 30.50
-0.57 (-1.83%)
At close: May 12, 2026
SHE:301258 Market Cap
SHE:301258 has a market cap or net worth of 2.7 billion as of May 12, 2026. Its market cap has increased by 24.55% in one year.
Market Cap
2.70B
Enterprise Value
1.54B
Revenue
412.51M
Ranking
n/a
PE Ratio
73.05
Stock Price
30.50
Market Cap Chart
Since March 29, 2022, SHE:301258's market cap has decreased from 6.10B to 2.70B, a decrease of -55.69%. That is a compound annual growth rate of -17.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 2.70B | -7.29% |
| Dec 31, 2025 | 2.91B | 35.37% |
| Dec 31, 2024 | 2.15B | -27.24% |
| Dec 29, 2023 | 2.96B | -17.76% |
| Dec 30, 2022 | 3.60B | -41.00% |
| Mar 29, 2022 | 6.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hubei Goto Biopharm | 3.22B |
| Shenzhen Bioeasy Biotechnology | 3.20B |
| Jiangsu Sihuan Bioengineering | 3.19B |
| Shanghai Model Organisms Center | 3.13B |
| Landfar Bio-medicine | 3.12B |
| Shandong Sito Bio-technology | 2.95B |
| Jilin Jian Yisheng Pharmaceutical | 2.77B |
| Shanghai Universal Biotech | 2.76B |